Scotts Miracle-Gro (SMG) Common Equity (2009 - 2026)

Scotts Miracle-Gro has disclosed Common Equity across 18 years of filings, most recently posting -$286.5 million for Q1 2026.

• Common Equity for Q1 2026 came in at -$286.5 million, up 1.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$286.5 million (up 1.24% YoY), and the FY2025 annual result was -$357.5 million, up 8.47% from the prior year.
• Common Equity came in at -$286.5 million for Q1 2026 at Scotts Miracle-Gro, up from -$500.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $975.0 million in Q2 2022 to a low of -$500.6 million in Q4 2025.
• The 5-year median for Common Equity is -$210.9 million (2024), against an average of -$45.6 million.
• Across the five-year window, Common Equity climbed 22.47% in 2022 and sank 747.73% in 2023, its largest moves.
• Scotts Miracle-Gro's Common Equity stood at $59.5 million in 2022, then tumbled by 747.73% to -$385.4 million in 2023, then decreased by 24.42% to -$479.5 million in 2024, then slipped by 4.4% to -$500.6 million in 2025, then jumped by 42.77% to -$286.5 million in 2026.
• The last three Common Equity figures came in at -$286.5 million (Q1 2026), -$500.6 million (Q4 2025), and -$357.5 million (Q3 2025), per Business Quant data.